A detailed history of Mcdonald Partners LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mcdonald Partners LLC holds 32,397 shares of GILD stock, worth $3.04 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
32,397
Previous 21,717 49.18%
Holding current value
$3.04 Million
Previous $1.49 Million 82.21%
% of portfolio
0.7%
Previous 0.41%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$66.59 - $83.99 $711,181 - $897,013
10,680 Added 49.18%
32,397 $2.72 Million
Q2 2024

Jul 17, 2024

SELL
$63.15 - $72.88 $192,291 - $221,919
-3,045 Reduced 12.3%
21,717 $1.49 Million
Q1 2024

Apr 15, 2024

SELL
$71.58 - $87.29 $362,481 - $442,036
-5,064 Reduced 16.98%
24,762 $1.81 Million
Q4 2023

Feb 12, 2024

SELL
$73.27 - $83.09 $528,789 - $599,660
-7,217 Reduced 19.48%
29,826 $2.42 Million
Q3 2023

Oct 30, 2023

BUY
$73.94 - $80.67 $169,174 - $184,572
2,288 Added 6.58%
37,043 $2.78 Million
Q2 2023

Jul 17, 2023

BUY
$76.01 - $86.7 $19,230 - $21,935
253 Added 0.73%
34,755 $2.68 Million
Q1 2023

Apr 19, 2023

SELL
$77.31 - $88.08 $47,159 - $53,728
-610 Reduced 1.74%
34,502 $2.86 Million
Q4 2022

Jan 18, 2023

SELL
$62.32 - $89.47 $58,206 - $83,564
-934 Reduced 2.59%
35,112 $0
Q3 2022

Oct 21, 2022

SELL
$59.54 - $68.01 $755,800 - $863,318
-12,694 Reduced 26.04%
36,046 $2.22 Million
Q2 2022

Jul 25, 2022

BUY
$57.72 - $65.01 $188,744 - $212,582
3,270 Added 7.19%
48,740 $3.01 Million
Q1 2022

Apr 29, 2022

BUY
$57.92 - $72.58 $2.63 Million - $3.29 Million
45,393 Added 58951.95%
45,470 $2.7 Million
Q4 2021

Jan 31, 2022

SELL
$64.88 - $73.64 $2.82 Million - $3.2 Million
-43,487 Reduced 99.82%
77 $5,000
Q3 2021

Nov 24, 2021

SELL
$67.69 - $73.03 $227,979 - $245,965
-3,368 Reduced 7.18%
43,564 $3.04 Million
Q3 2021

Oct 28, 2021

BUY
$67.69 - $73.03 $223,309 - $240,925
3,299 Added 7.56%
46,932 $3.28 Million
Q2 2021

Nov 24, 2021

SELL
$63.47 - $69.35 $221,002 - $241,476
-3,482 Reduced 7.39%
43,633 $3.01 Million
Q2 2021

Jul 23, 2021

BUY
$63.47 - $69.35 $537,400 - $587,186
8,467 Added 21.91%
47,115 $3.24 Million
Q1 2021

Nov 24, 2021

SELL
$60.0 - $68.46 $214,860 - $245,155
-3,581 Reduced 8.48%
38,648 $2.5 Million
Q1 2021

Apr 15, 2021

BUY
$60.0 - $68.46 $519,600 - $592,863
8,660 Added 25.8%
42,229 $2.73 Million
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $1.9 Million - $2.17 Million
33,569 New
33,569 $1.96 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mcdonald Partners LLC Portfolio

Follow Mcdonald Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdonald Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcdonald Partners LLC with notifications on news.